{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:06:41Z","timestamp":1789776401329,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2 diabetes (T2D) is characterized by insulin resistance and reduced functional \u03b2-cell mass. Developmental differences, failure of adaptive expansion and loss of \u03b2-cells via \u03b2-cell death or de-differentiation have emerged as the possible causes of this reduced \u03b2-cell mass. We hypothesized that the proliferative response to mitogens of human \u03b2-cells from T2D donors is reduced and that this might contribute to the development and progression of T2D. Here, we demonstrate that the proliferative response of human \u03b2-cells from T2D donors in response to cdk6 and cyclin D3 is indeed dramatically impaired. We show that this is accompanied by increased nuclear abundance of the cell cycle inhibitor, p27<jats:sup>kip1<\/jats:sup>. Increasing nuclear abundance of p27<jats:sup>kip1<\/jats:sup> by adenoviral delivery decreases the proliferative response of \u03b2-cells from non-diabetic donors, mimicking T2D \u03b2-cells. However, while both p27<jats:sup>kip1<\/jats:sup> gene silencing and downregulation by Skp2 overexpression increased similarly the proliferative response of human \u03b2-cells, only Skp2 was capable of inducing a significant human \u03b2-cell expansion. Skp2 was also able to double the proliferative response of T2D \u03b2-cells. These studies define c-Myc as a central Skp2 target for the induction of cell cycle entry, expansion and regeneration of human T2D \u03b2-cells.<\/jats:p>","DOI":"10.1038\/srep28461","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T08:52:57Z","timestamp":1467795177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Definition of a Skp2-c-Myc Pathway to Expand Human Beta-cells"],"prefix":"10.1038","volume":"6","author":[{"given":"Shiwani","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Roel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Tanwir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Perianayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie M.","family":"Fiaschi-Taesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"BFsrep28461_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mam.2014.12.002","volume":"42","author":"EU Alejandro","year":"2015","unstructured":"Alejandro, E. U. et al. Natural history of beta-cell adaptation and failure in type 2 diabetes. Mol. Aspects Med. 42, 19\u201341 (2015).","journal-title":"Mol. Aspects Med."},{"key":"BFsrep28461_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrendo.2015.9","volume":"11","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. Diabetes mellitus\u2013advances and challenges in human beta-cell proliferation. Nat. Rev. Endocrinol. 11, 201\u201312 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFsrep28461_CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3945\/an.113.005488","volume":"5","author":"AK Linnemann","year":"2014","unstructured":"Linnemann, A. K., Baan, M. & Davis, D. B. Pancreatic beta-cell proliferation in obesity. Adv. Nutr. 5, 278\u201388 (2014).","journal-title":"Adv. Nutr."},{"key":"BFsrep28461_CR4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2337\/dc12-2211","volume":"36","author":"PW Franks","year":"2013","unstructured":"Franks, P. W., Pearson, E. & Florez, J. C. Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls and prospects. Diabetes Care. 36, 1413\u201321 (2013).","journal-title":"Diabetes Care."},{"key":"BFsrep28461_CR5","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra0906948","volume":"363","author":"MI McCarthy","year":"2010","unstructured":"McCarthy, M. I. Genomics, type 2 diabetes and obesity. N. Engl. J. Med. 363, 2339\u201350 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep28461_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981\u201390 (2012).","journal-title":"Nat. Genet."},{"key":"BFsrep28461_CR7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.609","volume":"42","author":"BF Voight","year":"2010","unstructured":"Voight, B. F. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579\u201389 (2010).","journal-title":"Nat. Genet."},{"key":"BFsrep28461_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A. E. et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 52, 102\u201310 (2003).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","volume":"10","author":"J Rahier","year":"2008","unstructured":"Rahier, J. et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes. Metab. 10, Suppl 4 32\u201342 (2008).","journal-title":"Diabetes Obes. Metab."},{"key":"BFsrep28461_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.18632\/aging.100350","volume":"3","author":"U Gunasekaran","year":"2011","unstructured":"Gunasekaran, U. & Gannon, M. Type 2 diabetes and the aging pancreatic beta cell. Aging. 3, 565\u201375 (2011).","journal-title":"Aging."},{"key":"BFsrep28461_CR11","doi-asserted-by":"crossref","unstructured":"Abdulreda, M. H., Caicedo, A. & Berggren, P. O. Transplantation into the anterior chamber of the eye for longitudinal, non-invasive in vivo imaging with single-cell resolution in real-time. JoVE. e50466 (2013).","DOI":"10.3791\/50466"},{"key":"BFsrep28461_CR12","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00125-010-1809-6","volume":"53","author":"AE Butler","year":"2010","unstructured":"Butler, A. E. et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia. 53, 2167\u201376 (2010).","journal-title":"Diabetologia."},{"key":"BFsrep28461_CR13","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/jc.2012-1206","volume":"97","author":"BE Gregg","year":"2012","unstructured":"Gregg, B. E. et al. Formation of a human beta-cell population within pancreatic islets is set early in life. J. Clin. Endocrinol. Metab. 97, 3197\u2013206 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep28461_CR14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2337\/db07-1369","volume":"57","author":"JJ Meier","year":"2008","unstructured":"Meier, J. J. et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes. 57, 1584\u201394 (2008).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm1187","volume":"11","author":"T Uchida","year":"2005","unstructured":"Uchida, T. et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med. 11, 175\u201382 (2005).","journal-title":"Nat. Med."},{"key":"BFsrep28461_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2013.05.003","volume":"375","author":"J Taneera","year":"2013","unstructured":"Taneera, J. et al. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes. Mol. Cell. Endocrinol. 375, 35\u201342 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFsrep28461_CR17","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.2337\/db06-0861","volume":"55","author":"L Rachdi","year":"2006","unstructured":"Rachdi, L. et al. Differential effects of p27 in regulation of beta-cell mass during development, neonatal period and adult life. Diabetes. 55, 3520\u20138 (2006).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR18","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1073\/pnas.0503484102","volume":"102","author":"SK Karnik","year":"2005","unstructured":"Karnik, S. K. et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. PNAS. 102, 14659\u201364 (2005).","journal-title":"PNAS."},{"key":"BFsrep28461_CR19","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2337\/db06-0249","volume":"55","author":"S Georgia","year":"2006","unstructured":"Georgia, S. & Bhushan, A. p27 Regulates the transition of beta-cells from quiescence to proliferation. Diabetes. 55, 2950\u20136 (2006).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR20","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1128\/MCB.02300-07","volume":"28","author":"MD Larrea","year":"2008","unstructured":"Larrea, M. D. et al. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol. Cell. Biol. 28, 6462\u201372 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep28461_CR21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2337\/db08-0631","volume":"58","author":"N Fiaschi-Taesch","year":"2009","unstructured":"Fiaschi-Taesch, N. et al. Survey of the human pancreatic beta-cell G1\/S proteome reveals a potential therapeutic role for cdk-6 and cyclin D1 in enhancing human beta-cell replication and function in vivo. Diabetes. 58, 882\u201393 (2009).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR22","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/db12-0777","volume":"62","author":"NM Fiaschi-Taesch","year":"2013","unstructured":"Fiaschi-Taesch, N. M. et al. Human pancreatic beta-cell G1\/S molecule cell cycle atlas. Diabetes. 62, 2450\u20139 (2013).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR23","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/db12-0778","volume":"62","author":"NM Fiaschi-Taesch","year":"2013","unstructured":"Fiaschi-Taesch, N. M. et al. Cytoplasmic-nuclear trafficking of G1\/S cell cycle molecules and adult human beta-cell replication: a revised model of human beta-cell G1\/S control. Diabetes. 62, 2460\u201370 (2013).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR24","first-page":"11","volume":"1825","author":"Z Wang","year":"2012","unstructured":"Wang, Z. et al. Skp2: a novel potential therapeutic target for prostate cancer. Biochim. Biophys. Acta. 1825, 11\u20137 (2012).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFsrep28461_CR25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S1097-2765(03)00173-4","volume":"11","author":"SY Kim","year":"2003","unstructured":"Kim, S. Y. et al. Skp2 regulates Myc protein stability and activity. Mol. Cell. 11, 1177\u201388 (2003).","journal-title":"Mol. Cell."},{"key":"BFsrep28461_CR26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1097-2765(03)00193-X","volume":"11","author":"N von der Lehr","year":"2003","unstructured":"von der Lehr, N. et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell. 11, 1189\u2013200 (2003).","journal-title":"Mol. Cell."},{"key":"BFsrep28461_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1073\/pnas.1208334110","volume":"110","author":"Q Zhang","year":"2013","unstructured":"Zhang, Q. et al. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. PNAS. 110, 978\u201383 (2013).","journal-title":"PNAS."},{"key":"BFsrep28461_CR28","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2337\/db14-1885","volume":"64","author":"S Tiwari","year":"2015","unstructured":"Tiwari, S. et al. Early and Late G1\/S Cyclins and Cdks Act Complementarily to Enhance Authentic Human beta-Cell Proliferation and Expansion. Diabetes. 64, 3485\u201398 (2015).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR29","doi-asserted-by":"crossref","unstructured":"Chen, H. et al. Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human Beta Cells. Diabetes. (2015).","DOI":"10.2337\/db15-0083"},{"key":"BFsrep28461_CR30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","volume":"8","author":"IM Chu","year":"2008","unstructured":"Chu, I. M., Hengst, L. & Slingerland, J. M. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer. 8, 253\u201367 (2008).","journal-title":"Nat. Rev. Cancer."},{"key":"BFsrep28461_CR31","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1172\/JCI32198","volume":"117","author":"L Zhong","year":"2007","unstructured":"Zhong, L. et al. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. JCI. 117, 2869\u201376 (2007).","journal-title":"JCI"},{"key":"BFsrep28461_CR32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1349-7006.2009.01196.x","volume":"100","author":"K Kitagawa","year":"2009","unstructured":"Kitagawa, K., Kotake, Y. & Kitagawa, M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci. 100, 1374\u201381 (2009).","journal-title":"Cancer Sci."},{"key":"BFsrep28461_CR33","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1210\/me.2011-1074","volume":"25","author":"E Karslioglu","year":"2011","unstructured":"Karslioglu, E. et al. cMyc is a principal upstream driver of beta-cell proliferation in rat insulinoma cell lines and is an effective mediator of human beta-cell replication. Mol. Endocrinol. 25, 1760\u201372 (2011).","journal-title":"Mol. Endocrinol."},{"key":"BFsrep28461_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","volume":"21","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat. Med. 21, 383\u20138 (2015).","journal-title":"Nat. Med."},{"key":"BFsrep28461_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","volume":"10","author":"AV Matveyenko","year":"2008","unstructured":"Matveyenko, A. V. & Butler, P. C. Relationship between beta-cell mass and diabetes onset. Diabetes Obes. Metab. 10 (Suppl 4), 23\u201331 (2008).","journal-title":"Diabetes Obes. Metab."},{"key":"BFsrep28461_CR36","doi-asserted-by":"crossref","first-page":"e67454","DOI":"10.1371\/journal.pone.0067454","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Regional differences in islet distribution in the human pancreas\u2013preferential beta-cell loss in the head region in patients with type 2 diabetes. PloS One. 8, e67454 (2013).","journal-title":"PloS One."},{"key":"BFsrep28461_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc12-0421","volume":"36","author":"Y Saisho","year":"2013","unstructured":"Saisho, Y. et al. beta-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 36, 111\u20137 (2013).","journal-title":"Diabetes Care."},{"key":"BFsrep28461_CR38","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/en.2009-1277","volume":"151","author":"SC Hanley","year":"2010","unstructured":"Hanley, S. C. et al. {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology. 151, 1462\u201372 (2010).","journal-title":"Endocrinology."},{"key":"BFsrep28461_CR39","doi-asserted-by":"crossref","first-page":"e28050","DOI":"10.1371\/journal.pone.0028050","volume":"6","author":"F Folli","year":"2011","unstructured":"Folli, F. et al. Altered insulin receptor signalling and beta-cell cycle dynamics in type 2 diabetes mellitus. PloS One. 6, e28050 (2011).","journal-title":"PloS One."},{"key":"BFsrep28461_CR40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrm3562","volume":"14","author":"N Mailand","year":"2013","unstructured":"Mailand, N., Gibbs-Seymour, I. & Bekker-Jensen, S. Regulation of PCNA-protein interactions for genome stability. Nat. Rev. Mol. Cell Biol. 14, 269\u201382 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFsrep28461_CR41","first-page":"417390","volume":"2012","author":"ST Chen","year":"2012","unstructured":"Chen, S. T., Fu, S. H., Hsu, S., Huang, Y. Y. & Hsu, B. R. Synergistic Effect of Hyperglycemia and p27(kip1) Suppression on Adult Mouse Islet Beta Cell Replication. Int. J. Endocrinol. 2012, 417390 (2012).","journal-title":"Int. J. Endocrinol."},{"key":"BFsrep28461_CR42","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1158\/1541-7786.MCR-12-0718","volume":"11","author":"X Li","year":"2013","unstructured":"Li, X. et al. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression. Mol. Cancer Res. 11, 1437\u201347 (2013).","journal-title":"Mol. Cancer Res."},{"key":"BFsrep28461_CR43","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2337\/db11-0802","volume":"61","author":"MR Metukuri","year":"2012","unstructured":"Metukuri, M. R. et al. ChREBP mediates glucose-stimulated pancreatic beta-cell proliferation. Diabetes. 61, 2004\u201315 (2012).","journal-title":"Diabetes."},{"key":"BFsrep28461_CR44","doi-asserted-by":"crossref","first-page":"35375","DOI":"10.1074\/jbc.M105020200","volume":"276","author":"JC Jonas","year":"2001","unstructured":"Jonas, J. C. et al. High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells. JBC. 276, 35375\u201381 (2001).","journal-title":"JBC."},{"key":"BFsrep28461_CR45","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2337\/diabetes.51.6.1793","volume":"51","author":"DR Laybutt","year":"2002","unstructured":"Laybutt, D. R. et al. Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression and diabetes. Diabetes. 51, 1793\u2013804 (2002).","journal-title":"Diabetes."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep28461","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:04:59Z","timestamp":1672851899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep28461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,13]]}},"alternative-id":["BFsrep28461"],"URL":"https:\/\/doi.org\/10.1038\/srep28461","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]},"assertion":[{"value":"10 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28461"}}